Study of microRNA expression profiling as biomarkers for colorectal cancer patients in Lebanon
- 21 December 2021
- journal article
- research article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 16 (2) , 1-8
Abstract
The high incidence and mortality rates of colorectal cancer (CRC) reveal its hazardous effect globally. Thus, it is important to diagnose CRC at an early stage to decrease its burden and improve survival rates. Previous studies have investigated the role of short non‑coding microRNAs (miRNAs or miRs) in numerous types of cancer, including CRC. Previous studies have been performed to investigate the role of miRNAs as biomarkers in diagnosis, prognosis and prediction of CRC development. The aim of the present retrospective study was to identify the expression levels of miR‑31, miR‑145, miR‑146b and miR‑186 to highlight their role in CRC diagnosis and progression at different stages of the disease (precancerous polyp, adenoma and adenocarcinoma) in a Lebanese population. The expression levels of miRNAs was revealed using TaqMan reverse transcription‑quantitative PCR on formalin‑fixed paraffin‑embedded tissues from Lebanese patients at different stages; their diagnostic value was determined using a receiver operating characteristics curve. Compared with healthy controls, miR‑31 was upregulated (P<0.0001) at all stages. By contrast, miR‑145, miR‑186, and miR‑146b were significantly downregulated at all stages (P<0.0001, P=0.0009 and P=0.0241, respectively). Of the four miRNAs studied, miR‑31 and miR‑145 were identified as potentially useful diagnostic factors, with an area under the curve of 0.7771 and 0.8269 and diagnostic accuracy of 71.3 and 78.5%, respectively. These data suggested that miR‑31 and miR‑145, upon further clinical validation, may be used as potential diagnostic biomarkers for the early detection of CRC at the polyp stage.Keywords
This publication has 51 references indexed in Scilit:
- Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancerBMC Cancer, 2012
- The Role of MicroRNAs in Colorectal CancerThe Cancer Journal, 2012
- Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancerHuman Mutation, 2012
- MicroRNAs as Novel Biomarkers in Colorectal CancerFrontiers in Genetics, 2012
- Inhibitory effects of miR-146b-5p on cell migration and invasion of pancreatic cancer by targeting MMP16Current Medical Science, 2011
- Overexpression of the Lung Cancer-Prognostic miR-146b MicroRNAs Has a Minimal and Negative Effect on the Malignant Phenotype of A549 Lung Cancer CellsPLOS ONE, 2011
- MiR-146b-5p Suppresses EGFR Expression and ReducesIn VitroMigration and Invasion of GliomaCancer Investigation, 2010
- Breast Cancer Metastasis Suppressor 1 Up-regulates miR-146, Which Suppresses Breast Cancer MetastasisCancer Research, 2009
- Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal CancerOncology, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001